Overview

PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Evaluate the effect of age on the PK of two different doses of EMSAM.
Phase:
Phase 4
Details
Lead Sponsor:
Somerset Pharmaceuticals
Treatments:
Selegiline